Johnson & Johnson in the NEWS

Yesterday, February 18, 2026, Johnson & Johnson (JNJ) announced a more than $1 billion investment in a next generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. This new facility will further expand the Company’s U.S. manufacturing capacity as it advances its industry leading portfolio and pipeline of transformational medicines for cancer, immune-mediated and . . .